Full Alliance Group (FAGI) has announced significant progress in commercializing its subsidiary Aquaox Pure Solutions' nanobubble-enhanced hypochlorous acid (HOCl) technology. The platform represents an innovative solution targeting the $60 billion global disinfectant and skincare markets. The company's proprietary technology uses stabilized nanobubbles to enhance HOCl's stability and efficacy, creating a clean-label, broad-spectrum antimicrobial solution. Aquaox is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors. The company's Tampa facility is expanding to support branded and white-label production, with applications ranging from personal hygiene to medical-grade disinfection. The technology offers industrial-strength performance with skin-safe application, positioning Aquaox as a platform for scalable innovation in multiple markets.
Full Alliance Group (FAGI) ha annunciato importanti progressi nella commercializzazione della tecnologia a base di acido ipocloroso (HOCl) potenziata da nanobolle della sua controllata Aquaox Pure Solutions. Questa piattaforma rappresenta una soluzione innovativa rivolta ai mercati globali dei disinfettanti e della cura della pelle, del valore di 60 miliardi di dollari. La tecnologia proprietaria dell'azienda utilizza nanobolle stabilizzate per migliorare la stabilit脿 e l'efficacia dell'HOCl, creando una soluzione antimicrobica a etichetta pulita e ad ampio spettro. Aquaox sta cercando partnership strategiche di licenza nei settori sanitario, della cura personale, industriale e consumer. Lo stabilimento di Tampa dell'azienda si sta ampliando per supportare la produzione sia a marchio proprio che in white-label, con applicazioni che spaziano dall'igiene personale alla disinfezione di grado medico. La tecnologia offre prestazioni industriali con un'applicazione sicura per la pelle, posizionando Aquaox come una piattaforma per l'innovazione scalabile in diversi mercati.
Full Alliance Group (FAGI) ha anunciado avances significativos en la comercializaci贸n de la tecnolog铆a de 谩cido hipocloroso (HOCl) mejorada con nanoburbujas de su subsidiaria Aquaox Pure Solutions. Esta plataforma representa una soluci贸n innovadora dirigida a los mercados globales de desinfectantes y cuidado de la piel, valorados en 60 mil millones de d贸lares. La tecnolog铆a propietaria de la empresa utiliza nanoburbujas estabilizadas para mejorar la estabilidad y eficacia del HOCl, creando una soluci贸n antimicrobiana de etiqueta limpia y de amplio espectro. Aquaox est谩 buscando asociaciones estrat茅gicas de licencia en los sectores de salud, cuidado personal, industrial y de consumo. La planta de Tampa de la empresa se est谩 ampliando para apoyar la producci贸n de marca propia y de etiqueta blanca, con aplicaciones que van desde la higiene personal hasta la desinfecci贸n de grado m茅dico. La tecnolog铆a ofrece un rendimiento industrial con aplicaci贸n segura para la piel, posicionando a Aquaox como una plataforma para la innovaci贸n escalable en m煤ltiples mercados.
Full Alliance Group (FAGI) a annonc茅 des progr猫s significatifs dans la commercialisation de la technologie 脿 base d'acide hypochloreux (HOCl) am茅lior茅e par nanobulles de sa filiale Aquaox Pure Solutions. Cette plateforme repr茅sente une solution innovante ciblant les march茅s mondiaux des d茅sinfectants et des soins de la peau, 茅valu茅s 脿 60 milliards de dollars. La technologie propri茅taire de l'entreprise utilise des nanobulles stabilis茅es pour renforcer la stabilit茅 et l'efficacit茅 de l'HOCl, cr茅ant ainsi une solution antimicrobienne 脿 large spectre et 脿 茅tiquette propre. Aquaox recherche des partenariats strat茅giques de licence dans les secteurs de la sant茅, des soins personnels, de l'industrie et de la consommation. L'usine de Tampa de l'entreprise est en expansion pour soutenir la production sous marque propre et en marque blanche, avec des applications allant de l'hygi猫ne personnelle 脿 la d茅sinfection de qualit茅 m茅dicale. La technologie offre des performances industrielles avec une application s没re pour la peau, positionnant Aquaox comme une plateforme d'innovation 茅volutive sur plusieurs march茅s.
Full Alliance Group (FAGI) hat bedeutende Fortschritte bei der Kommerzialisierung der nanoblasenverst盲rkten Hypochlors盲ure (HOCl)-Technologie seiner Tochtergesellschaft Aquaox Pure Solutions bekannt gegeben. Die Plattform stellt eine innovative L枚sung dar, die auf den 60 Milliarden Dollar schweren globalen Markt f眉r Desinfektionsmittel und Hautpflege abzielt. Die firmeneigene Technologie nutzt stabilisierte Nanoblasen, um die Stabilit盲t und Wirksamkeit von HOCl zu verbessern und so eine saubere, breit wirksame antimikrobielle L枚sung zu schaffen. Aquaox strebt strategische Lizenzpartnerschaften in den Bereichen Gesundheitswesen, K枚rperpflege, Industrie und Konsumg眉ter an. Die Produktionsst盲tte des Unternehmens in Tampa wird erweitert, um sowohl Marken- als auch White-Label-Produktion zu unterst眉tzen, mit Anwendungen von der pers枚nlichen Hygiene bis hin zur medizinischen Desinfektion. Die Technologie bietet industrielle Leistungsf盲higkeit bei hautvertr盲glicher Anwendung und positioniert Aquaox als Plattform f眉r skalierbare Innovationen in verschiedenen M盲rkten.
Positive
Technology targets a large $60 billion global market opportunity
Proprietary nanobubble technology enhances HOCl stability and efficacy
Multiple revenue streams through branded products and strategic licensing opportunities
Clean-label formula meets growing demand for non-toxic alternatives
Expanding production facility in Tampa for increased manufacturing capacity
Negative
Early stage of commercialization with unproven market acceptance
Potential competition from established disinfectant manufacturers
Success dependent on securing strategic partnerships and licensing agreements
TAMPA, FL / / June 10, 2025 / Full Alliance Group, Inc. (OTC PINK:FAGI) today announced major strides in the commercial development of its recently formed subsidiary, Aquaox Pure Solutions, LLC. The company's breakthrough nanobubble-enhanced hypochlorous acid (HOCl) platform represents a next-generation solution for the $60 billion global disinfectant and skincare markets.
Aquaox's proprietary approach uses stabilized nanobubbles-microscopic gas-filled structures-to significantly improve the stability and efficacy of HOCl, a naturally occurring antimicrobial agent widely recognized for its safety and broad-spectrum performance. The result is a highly effective, clean-label formula well-suited for a range of fast-growing markets, including hospital-grade disinfection, dermatology, wound care, agriculture, and food safety.
"We believe Aquaox Pure Solutions offers one of the most scalable and investable HOCl technologies available today," said Michel Van Schaik, President of Aquaox Pure Solutions. "Our formulations are clean, potent, and uniquely shelf-stable-offering a meaningful advantage over conventional chlorine-based options."
Built for Scale and Strategic Licensing Full Alliance Group is exploring strategic licensing and commercialization partnerships with companies across healthcare, personal care, industrial, and consumer sectors. Early-stage discussions with contract manufacturers and brand developers reflect growing interest in safe, sustainable antimicrobial solutions.
As part of its go-to-market strategy, Aquaox Pure Solutions is evaluating categories that include:
Personal hygiene and pet care
Oral and skincare health
Commercial sanitation and food processing
Medical-grade disinfection and wound care
Agricultural and environmental purification
Production and Global Readiness The company's Tampa, Florida-based production facility is expanding to support both branded and white-label formats. With e-commerce-ready packaging and a strict commitment to clean-label ingredients-free from stabilizers, alcohols, or bleach-Aquaox is positioning itself to meet international regulatory standards and rising consumer demand for non-toxic alternatives.
A Platform Technology, Not Just a Product With its nanobubble HOCl formulations, Aquaox delivers the rare combination of industrial-strength performance and skin-safe application-bridging critical gaps across multiple sectors.
"This isn't just a disinfectant-it's a platform for scalable innovation," said Bill Heneghan. "We see long-term potential to drive licensing revenue while contributing meaningfully to public health and environmental safety."
Pure Aquaox Solutions, LLC Brett Phillips [email protected] (800) 895-4415
About Full Alliance Group, Inc.
Full Alliance Group, Inc. (OTC:FAGI) is a holding company in the health and wellness sector. FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.
About Aquaox Pure Solutions, LLC
Aquaox Pure Solutions, LLC is a leading manufacturer of hypochlorous acid products enhanced with nanobubble technology. Committed to sustainability and efficacy, PureAquaox serves diverse markets with applications ranging from healthcare to consumer products.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Full Alliance Group, Inc.
View the original on ACCESS Newswire
FAQ
What is Full Alliance Group's (FAGI) new technology for disinfectants?
FAGI's subsidiary Aquaox Pure Solutions has developed a nanobubble-enhanced hypochlorous acid (HOCl) technology that improves stability and efficacy for disinfection and skincare applications.
What markets is FAGI targeting with its Aquaox Pure Solutions technology?
The company is targeting multiple markets including hospital-grade disinfection, dermatology, wound care, agriculture, food safety, personal hygiene, and pet care.
How does FAGI plan to commercialize its Aquaox Pure Solutions technology?
FAGI is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors, while expanding its Tampa facility for branded and white-label production.
What is the market size for FAGI's disinfectant technology?
The technology targets the global disinfectant and skincare markets, valued at $60 billion.
What advantages does FAGI's Aquaox technology offer over conventional disinfectants?
The technology offers a clean-label, non-toxic formula free from stabilizers, alcohols, or bleach, while providing industrial-strength performance with skin-safe application.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
